Eagle Pharmaceuticals Inc (EGRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1641
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Eagle Pharmaceuticals Inc (EGRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eagle Pharmaceuticals Inc (Eagle) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s key commercial product portfolio encompasses pharmaceutical injectables, including Ryanodex for exertional heatstroke; Bendeka, and Belrapzo, both for the treatment of chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin’s lymphoma (NHL). Pipeline products of the company include EP-4104 (dantrolene sodium) for exertional heat stroke (EHS) and nerve agent exposure; EGL-5385-C-1701 (fulvestrant) and Vasopressin injection for blood pressure. The company’s products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in New Jersey, the US.

Eagle Pharmaceuticals Inc Key Recent Developments

Mar 02,2020 Eagle Pharmaceuticals reports fourth quarter and full year 2019 results
Jan 08,2020 Tyme, Eagle Pharmaceuticals partner for cancer candidate oral
Nov 14,2019 Eagle Pharmaceuticals announces departure of Douglas L. Braunstein from Board of Directors
Nov 12,2019 Eagle Pharmaceuticals reports third quarter 2019 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Eagle Pharmaceuticals Inc – Key Facts
Eagle Pharmaceuticals Inc – Key Employees
Eagle Pharmaceuticals Inc – Key Employee Biographies
Eagle Pharmaceuticals Inc – Major Products and Services
Eagle Pharmaceuticals Inc – History
Eagle Pharmaceuticals Inc – Company Statement
Eagle Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Eagle Pharmaceuticals Inc – Business Description
Product Category: License and Other Revenue
Performance
Product Category: Product Sales
Performance
Product Category: Royalty Revenue
Performance
Eagle Pharmaceuticals Inc – Corporate Strategy
Eagle Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Eagle Pharmaceuticals Inc – Strengths
Eagle Pharmaceuticals Inc – Weaknesses
Eagle Pharmaceuticals Inc – Opportunities
Eagle Pharmaceuticals Inc – Threats
Eagle Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Eagle Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2020: Eagle Pharmaceuticals reports fourth quarter and full year 2019 results
Jan 08, 2020: Tyme, Eagle Pharmaceuticals partner for cancer candidate oral
Nov 14, 2019: Eagle Pharmaceuticals announces departure of Douglas L. Braunstein from Board of Directors
Nov 12, 2019: Eagle Pharmaceuticals reports third quarter 2019 results
Aug 08, 2019: Eagle Pharmaceuticals reports second quarter 2019 results
May 07, 2019: Eagle Pharmaceuticals announces first quarter 2019 results
Feb 28, 2019: Eagle Pharmaceuticals reports fourth quarter and full year 2018 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Eagle Pharmaceuticals Inc, Key Facts
Eagle Pharmaceuticals Inc, Key Employees
Eagle Pharmaceuticals Inc, Key Employee Biographies
Eagle Pharmaceuticals Inc, Major Products and Services
Eagle Pharmaceuticals Inc, History
Eagle Pharmaceuticals Inc, Subsidiaries
Eagle Pharmaceuticals Inc, Key Competitors
Eagle Pharmaceuticals Inc, Ratios based on current share price
Eagle Pharmaceuticals Inc, Annual Ratios
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...1)
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...2)
Eagle Pharmaceuticals Inc, Interim Ratios
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Eagle Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Eagle Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Eagle Pharmaceuticals Inc, Ratio Charts
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Eagle Pharmaceuticals Inc (EGRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chesswood Group Limited (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Limited (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nilkamal Ltd:企業の戦略・SWOT・財務情報
    Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report Summary Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Panda Restaurant Group Inc:企業の戦略・SWOT・財務情報
    Panda Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Panda Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務情報
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Patara Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Patara Pharma Inc (Patara Pharma) is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of chronic inflammatory and fibrosis. The company develops anti-inflammatory therapeutics for lung diseases and immune disorders. It conducts clinical trials and in …
  • Mediaset S.p.A. (MS):企業の財務・戦略的SWOT分析
    Mediaset S.p.A. (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • MYnd Analytics Inc (MYND):医療機器:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析
    Summary Lyka Labs Ltd (Lyka Labs) is a developer and manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company offers development of various formulations which include lyophilized injections, differentiated dermatological formulation, dry powder injections, and o …
  • Pacific Gas and Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of targ …
  • Rockwell Automation Inc (ROK):企業の財務・戦略的SWOT分析
    Rockwell Automation Inc (ROK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • High Peak Royalties Ltd (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Celonic AG-製薬・医療分野:企業M&A・提携分析
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that provides contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of ac …
  • PepVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PepVax Inc (PepVax) is a biotechnology company that develops novel therapeutics for the treatment of cancer. The company provides pipeline product candidate portfolio such as HCA587, which is being developing to treat hepatocellular carcinoma and TFDP3, a drug candidate which is being used f …
  • Greatcell Solar Ltd (GSL):企業の財務・戦略的SWOT分析
    Greatcell Solar Ltd (GSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aura Light International AB:企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Alberta Treasury Branches:企業の戦略的SWOT分析
    Alberta Treasury Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆